The prognostic significance of soluble PD-1 and its ligands has previously been described in several malignancies, including melanoma, lung, and pancreatic cancers17–20, but this the first to report that soluble PD-1 is elevated in the circulation in HL patients. This evidence concerns the gene PDCD1 and Hodgkins lymphoma.